Recently, Kiselev et al., considering cell populations key in triggering pathological processes underlying the development of MS, performed pairwise DNA methylation profiling in CD4+ T lymphocytes and CD14+ monocytes. The gene discussed is CD4; the disease is myeloid sarcoma.